Answers are grounded in this paper and cite their sources.
A novel PCD/CUR self‐assembly approach for improved curcumin delivery to prostate cancer cells is described. The formation of PCD/CUR was confirmed using FTIR, DSC, TGA, and SEM/TEM, and their stability and solubility under physiological conditions was demonstrated. A mechanism for self‐assembly is proposed. Intracellular uptake of the self‐assemblies was studied by flow cytometry and immunofluorescence microscopy. The therapeutic efficacy was determined by cell proliferation and colony formation assays using C4‐2, DU145 and PC3 prostate cancer cells. The results suggest that the PCD/CUR formulation could be a useful system for improving curcumin delivery and its therapeutic efficacy in prostate cancer. magnified image
No takes yet. Share an insight, caveat, or question.
Yallapu et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: